An oxytocin-way to say no to cardiac diseases: Oxytocin-based inhalation therapy for attenuating pathogenesis-associated with Myocardial infarction: Inhalation of oxytocin decreases IRF3 (Interferon regulatory transcription factor-3), GM-CSF (Granulocyte-macrophage colony-stimulating factor) and GRK2(G protein-coupled receptor kinase) expression, inhibits undue leucocyte activation and invasion, suppresses recruitment of inflammatory cells, inhibits ventricular dilation, and promotes heart repair and survival, via up regulation of its target gene, 16/April/2018, 8.05 am